Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.
about
Epigenetic modifications in cancerArray-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arraysMass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location.Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays.Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesReplicative age induces mitotic recombination in the ribosomal RNA gene cluster of Saccharomyces cerevisiaeRenal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.Genome-wide Mapping of Copy Number Variations Using SNP Arrays.Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib)Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predispositionWidespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer.Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression.Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.Utilization of magnetic-activated cell sorting and high-density single nucleotide polymorphism microarrays improves diagnostic yield and prognostic value in clinical testing for patients with multiple myeloma and normal routine chromosome studyMonoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).Integration of cancer genomics with treatment selection: from the genome to predictive biomarkersPathogenesis and consequences of uniparental disomy in cancer.Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.TagRecon: high-throughput mutation identification through sequence tagging.Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patientsColorectal Cancer Mortality in Relation to Glucose - 6 - Phosphate Dehydrogenase Deficiency and Consanguinity in Sardinia: A Spatial Correlation AnalysisMutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.Multiplex Single Nucleotide Polymorphism Analyses.Genetic diversity, inbreeding and cancer.Fiber-Optic High-Resolution Genetic Screening Using Gold-Labeled Gene Probes
P2860
Q22242610-7FEA400D-8C90-42C2-B79E-87FE69A042E9Q24614789-6C902A35-47A9-403F-869F-3AD9F0042C84Q31048838-BF46CB00-E6D2-470A-A028-1FBA992B6CA1Q33607569-64DE8532-9BAE-405A-B627-68309A80CC03Q33788643-46339EC1-6978-4EF8-A603-990592EF0EA6Q33855439-86DC06DA-7019-48E4-BEBF-A95F9C233C1EQ33931096-7D15A310-CDEF-4C71-9D87-EA792B4A10C3Q34084819-E574BB1F-8C30-4F82-A232-55008CF5F4F8Q34139304-EF747048-FE84-4723-A1F8-6EC690BF69F9Q34574573-CD339A59-FD1A-49EE-87D3-BA751A582145Q35246828-7AE4C271-2F73-4214-BC84-42D1619DFFADQ35555414-F4D7E0BB-C955-46E7-AADA-610C26F7121CQ35856558-37381037-B1AA-4471-9763-24148FF355C5Q36152246-ACCD0098-F4EB-49A5-91D5-78AE35F56C6EQ36193269-7781A961-A4D7-4D6C-9898-A98718926E80Q36433299-415C2F2C-460D-4605-95FC-41D1F14C00A7Q37595614-CE5036F9-37EA-4EC7-BDD3-581662E33EAAQ37868831-26BACCCA-C695-4695-83C2-33F68F0A56D6Q39178745-521A1AC5-1AE6-452B-90A2-32315F31FCDFQ39743848-857A0088-9C2B-4FF1-B582-78B1DE0EF09EQ41744534-A4D520A4-6D9B-4796-9B45-4B867F9FD680Q42764596-026B7942-856F-4C50-BCBC-72786F5DD009Q47119967-4ADBBC62-0E46-45D4-8FE0-98DD98F7D8ABQ47164988-97BA7D20-7961-4C09-96B4-F93A1ED48820Q49959048-441288EB-DCD3-4964-A739-29ED8A614868Q51038448-44264DA9-CCDB-45C7-8D56-189369C03FECQ51145959-00F70D6D-E2D7-4CD5-92BA-D736D0364877Q58860484-FD978007-52FF-4A64-B878-3309F00F9F45
P2860
Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Emerging paradigms in cancer g ...... de polymorphism array studies.
@ast
Emerging paradigms in cancer g ...... de polymorphism array studies.
@en
type
label
Emerging paradigms in cancer g ...... de polymorphism array studies.
@ast
Emerging paradigms in cancer g ...... de polymorphism array studies.
@en
prefLabel
Emerging paradigms in cancer g ...... de polymorphism array studies.
@ast
Emerging paradigms in cancer g ...... de polymorphism array studies.
@en
P2093
P2860
P1433
P1476
Emerging paradigms in cancer g ...... de polymorphism array studies.
@en
P2093
Daniel A Notterman
Francis Barany
Gunter S Schemmann
Manny D Bacolod
Philip Paty
Sarah F Giardina
P2860
P304
P356
10.1158/0008-5472.CAN-08-3543
P407
P577
2009-01-20T00:00:00Z